Ethyl-eicosapentaenoic acid treatment in Huntington's disease: A placebo-controlled clinical trial.

Joaquim J Ferreira; Anne Rosser; David Craufurd; Ferdinando Squitieri; Nicholas Mallard; Bernhard Landwehrmeyer

doi:10.1002/mds.26308

Ethyl-eicosapentaenoic acid treatment in Huntington's disease: A placebo-controlled clinical trial.

Joaquim J Ferreira, Anne Rosser, David Craufurd, Ferdinando Squitieri, Nicholas Mallard, Bernhard Landwehrmeyer

Research output: Contribution to journal › Article › peer-review

Abstract

BACKGROUND: It has been suggested that treatment with ethyl-eicosapentaenoic acid (EPA) may improve motor function in patients with Huntington's disease (HD) with cytosine-adenine-guanine repeat numbers of

Original language	English
Journal	Movement disorders : official journal of the Movement Disorder Society
Volume	30
Issue number	10
DOIs	https://doi.org/10.1002/mds.26308
Publication status	Published - Sept 2015

Keywords

Huntington's disease
clinical trial
eicosapentaenoic acid
ethyl-EPA

Access to Document

10.1002/mds.26308

Cite this

@article{c7dd7f80cc70428b9436e09a8580bd70,

title = "Ethyl-eicosapentaenoic acid treatment in Huntington's disease: A placebo-controlled clinical trial.",

abstract = "BACKGROUND: It has been suggested that treatment with ethyl-eicosapentaenoic acid (EPA) may improve motor function in patients with Huntington's disease (HD) with cytosine-adenine-guanine repeat numbers of",

keywords = "Huntington's disease, clinical trial, eicosapentaenoic acid, ethyl-EPA",

author = "Ferreira, {Joaquim J} and Anne Rosser and David Craufurd and Ferdinando Squitieri and Nicholas Mallard and Bernhard Landwehrmeyer",

year = "2015",

month = sep,

doi = "10.1002/mds.26308",

language = "English",

volume = "30",

journal = "Movement disorders : official journal of the Movement Disorder Society",

issn = "1531-8257",

publisher = "John Wiley & Sons Ltd",

number = "10",

}

TY - JOUR

T1 - Ethyl-eicosapentaenoic acid treatment in Huntington's disease: A placebo-controlled clinical trial.

AU - Ferreira, Joaquim J

AU - Rosser, Anne

AU - Craufurd, David

AU - Squitieri, Ferdinando

AU - Mallard, Nicholas

AU - Landwehrmeyer, Bernhard

PY - 2015/9

Y1 - 2015/9

N2 - BACKGROUND: It has been suggested that treatment with ethyl-eicosapentaenoic acid (EPA) may improve motor function in patients with Huntington's disease (HD) with cytosine-adenine-guanine repeat numbers of

AB - BACKGROUND: It has been suggested that treatment with ethyl-eicosapentaenoic acid (EPA) may improve motor function in patients with Huntington's disease (HD) with cytosine-adenine-guanine repeat numbers of

KW - Huntington's disease

KW - clinical trial

KW - eicosapentaenoic acid

KW - ethyl-EPA

U2 - 10.1002/mds.26308

DO - 10.1002/mds.26308

M3 - Article

C2 - 26175332

SN - 1531-8257

VL - 30

JO - Movement disorders : official journal of the Movement Disorder Society

JF - Movement disorders : official journal of the Movement Disorder Society

IS - 10

ER -

Ethyl-eicosapentaenoic acid treatment in Huntington's disease: A placebo-controlled clinical trial.

Abstract

Keywords

Access to Document

Fingerprint

Cite this